Related Experiment Video
Updated: Apr 27, 2026
15:48
Tracking the Mammary Architectural Features and Detecting Breast Cancer with Magnetic Resonance Diffusion Tensor Imaging
Published on: December 15, 2014
25.0K
Diffusion weighted MRI in ovarian cancer
1Imperial College Healthcare NHS Trust, London, United Kingdom.
Current Opinion in Oncology
|July 16, 2014
Summary
Diffusion weighted MRI (DW-MRI) aids ovarian cancer management by characterizing masses and detecting peritoneal disease. It shows promise in assessing chemotherapy response and tumor heterogeneity through apparent diffusion coefficient (ADC) changes.
Area of Science:
- Oncology
- Radiology
- Medical Imaging
Background:
- Diffusion weighted MRI (DW-MRI) is increasingly researched for ovarian cancer management.
- Its applications span diagnosis, treatment response assessment, and understanding tumor heterogeneity.
Purpose of the Study:
- To discuss current and future clinical applications of DW-MRI in ovarian cancer.
- To highlight research interests in DW-MRI for ovarian cancer.
Main Methods:
- Review of recent research on DW-MRI in ovarian cancer.
- Analysis of DW-MRI's role in characterizing adnexal masses and peritoneal disease.
- Evaluation of apparent diffusion coefficient (ADC) changes for treatment response.
Main Results:
- DW-MRI effectively characterizes adnexal masses, with absent signal indicating benignity (high negative predictive value).
- High sensitivity and specificity are achieved in detecting malignant peritoneal implants due to high contrast resolution.
- Apparent diffusion coefficient (ADC) changes can predict chemotherapy response and reveal tumor heterogeneity.
Conclusions:
- DW-MRI is becoming established for preoperative confirmation of benign adnexal masses.
- Its use in detecting peritoneal disease and early chemotherapy response assessment remains an active research area with significant potential.
